Robert Narquizian Bio

Robert Joined Truffle Capital in April 2020. He has more than 20 years of experience in the Pharmaceutical and Biotech Industry. Scientist by formation, Robert has project led a number of projects from the initial idea all the way to phase 2 clinical trials -proof of concept studies. Robert has since contributed to a large number of pharma related transactions as Director of Business Development and Licensing at Roche, as head of Asia Pacific Global External R&D at Eli Lilly China and more recently through its own consulting firm. Robert graduated with a PhD in Chemistry from Glasgow, UK, a post-doc from Harvard University and an MBA from the London Business School.